Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ KMT2E Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5117037

Catalog No. PIPA5117037


Only null left
Add to Cart

Description

Description

Positive Samples: NCI-H460, 293T, Mouse brain Immunogen sequence: VELYTAFQHT PTSITLTASR VSKVNDKRRK KSGEKEQHIS KCKKAFREGS RKSSRVKGSA PEIDPSSDGS NFGWETKIKA WMDRYEEANN NQYSEGVQRE AQRIALRLGN GNDKKEMNKS DLNTNNLLFK PPVESHIQKN KKILKSAKDL PPDALIIEYR GKFMLREQFE ANGYFFKRPY PFVLFYSKFH GLEMCVDART FGNEARFIRR SCTPNAEVRH EIQDGTIHLY IYSIHSIPKG TEITIAFDFD YGNCKYKVDC ACLKENPECP VLKRSSESME NINSGYETRR KKGKKDKDIS K.

The mixed lineage leukemia (MLL) gene family comprise a group of Histone H3 lysine 4 (H3K4) methyltransferases within the larger SET1 family. The founding member MLL commonly undergoes translocations in infantile leukemia and displays increased expression in some adult myeloid leukemias. MLL2, also designated ALR, exists within a complex of proteins. MLL2 is important for mouse embryonic development and may be involved in adhesion-related cytoskeletal events affecting cell growth and survival. The MLL2 gene maps to the human locus 19q13.1, which is a frequent target of rearrangement or amplification in solid tumors. MLL3 or its paralogue MLL4 associate with activating signal cointegrator-2 (ASC-2), which regulates ligand-dependent H3K4 trimethylation and expression of LXR-target genes. MLL3 maps to a location on human chromosome 7 that is often deleted in myeloid disorders. MLL3 also exhibits higher expression in peripheral blood, placenta, pancreas, testis, and fetal thymus. MLL5 localizes to the nucleus and forms intranuclear protein complexes, which may regulate chromatin remodeling and cellular growth suppression. The gene encoding human MLL5 lies within chromosome band 7q22.3, a region deleted in cytogenetic aberrations of acute myeloid malignancies.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

KMT2E
Polyclonal
Unconjugated
KMT2E
1810033J14Rik; 9530077A04Rik; D230038D11Rik; HDCMC04P; histone-lysine N-methyltransferase 2E; histone-lysine N-methyltransferase MLL5; Inactive histone-lysine N-methyltransferase 2E; Inactive lysine N-methyltransferase 2E; KMT2E; lysine (K)-specific methyltransferase 2E; lysine methyltransferase 2E; lysine N-methyltransferase 2E; MGC70452; MLL5; myeloid/lymphoid or mixed-lineage leukemia 5; myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog, Drosophila); myeloid/lymphoid or mixed-lineage leukemia protein 5; Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog; NKp44L
Rabbit
Affinity chromatography
RUO
311968, 55904, 69188
-20°C, Avoid Freeze/Thaw Cycles
Liquid
ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
0.61 mg/mL
PBS with 50% glycerol and 0.09% sodium azide; pH 7.3
Q3UG20, Q8IZD2
KMT2E
Recombinant fusion protein containing a sequence corresponding to amino acids 200-500 of human MLL5 (NP_0611523).
100 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.